A multimarker approach, consisting of HE4, CA125 and CA72-4, can provide a more accurate tool for a differential diagnosis of patients with ovarian endometriotic cysts, other benign ovarian masses and ovarian cancer. Here, WFDC2 is linked to ovarian carcinoma.